1
2
3
4
5
6
7
8
9
10
11
12
13 | Licensing Program Analyst (LPA) Tuesday Cabiness conducted a subsequent visit to deliver the final findings for the allegation mentioned above. LPA met with Tyler Barnes, Operation Specialist and informed him the reason of the visit. Executive Director (ED) Bradlee Foerschner, was not available at the time of the visit. The following was determined:
It was alleged "Facility staff administered medication without reason". The allegation was not mentioned but addressed in conjunction with compliant control # (31-AS-20210125150526), dated January 2021. During the investigation, on 02/03/2021, 02/04/2021, 05/27/2022, 06/13/2022, and 06/20/2022, from various time frames, between 930am to 3:00pm, LPA reviewed medical and hospice records and other facility documents, as well as conducted interviews with the complainant, facility staff and other witnesses regarding the allegation. According to the information obtained, R1 started receiving hospice services on 12/29/2020, due to terminal illness and other chronic health conditions, which were further complicated by COVID related issues. LPA reviewed medical records, and it was documented that the prescription in question, Ativan was prescribed under hospice care, |